FMR LLC 13D and 13G filings for Syros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-11-10 11:55 am Purchase |
2022-11-09 | 13G | Syros Pharmaceuticals, Inc. SYRS |
FMR LLC | 104,614 0.516% |
104,614 (New Position) |
Filing |